publicEuropean Medicines Agency (EMA) · European Union · Updated Jul 20, 2026
CHMP Draft Agenda for Public Consultation on Thalassaemia and Sickle Cell Disease Guidelines
Sponsors and MAHs must review and align safety data collection and reporting protocols with the newly adopted guidelines while preparing for implementation of PRAC recommendations stemming from this meeting.
Signal ManagementICSRRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead
verifiedRegulatory action: Agenda
Read impact briefarrow_forward